These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19275788)

  • 21. Multidrug- and extensively drug-resistant tuberculosis: an emerging threat.
    Berry M; Kon OM
    Eur Respir Rev; 2009 Dec; 18(114):195-7. PubMed ID: 20956144
    [No Abstract]   [Full Text] [Related]  

  • 22. Directly observed and standardized treatment in an era of extensively drug-resistant tuberculosis.
    Chang KC; Leung CC; Tam CM
    Clin Infect Dis; 2009 Jun; 48(11):1632-3; author reply 1633-4. PubMed ID: 19416026
    [No Abstract]   [Full Text] [Related]  

  • 23. New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.
    Viney K; Linh NN; Gegia M; Zignol M; Glaziou P; Ismail N; Kasaeva T; Mirzayev F
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33833074
    [No Abstract]   [Full Text] [Related]  

  • 24. Summaries for patients. Incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
    Ann Intern Med; 2010 Oct; 153(8):I-62. PubMed ID: 20956693
    [No Abstract]   [Full Text] [Related]  

  • 25. Extensively drug-resistant tuberculosis: are we prepared enough?
    Bhan A
    Natl Med J India; 2007; 20(3):158-9. PubMed ID: 17874481
    [No Abstract]   [Full Text] [Related]  

  • 26. High rate of extensively drug-resistant tuberculosis in Indian AIDS patients.
    Singh S; Sankar MM; Gopinath K
    AIDS; 2007 Nov; 21(17):2345-7. PubMed ID: 18090285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistant tuberculosis in a 6 year old child.
    Suessmuth S; Bange FC; Gappa M
    Paediatr Respir Rev; 2007 Sep; 8(3):265-8. PubMed ID: 17868926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TB drugs chalk up rare win.
    Maxmen A
    Nature; 2012 Jul; 487(7408):413-4. PubMed ID: 22836975
    [No Abstract]   [Full Text] [Related]  

  • 29. The threat of extensively drug-resistant tuberculosis.
    Mohapatra PR
    Clin Infect Dis; 2007 Mar; 44(6):888-9. PubMed ID: 17304469
    [No Abstract]   [Full Text] [Related]  

  • 30. Unsexy tuberculosis.
    Reichman LB
    Lancet; 2009 Jan; 373(9657):28. PubMed ID: 19121719
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Sotgiu G; Lange C; Richardson MD; Matteelli A; Centis R; Eker B; Guenther G; Spanevello A; Migliori GB;
    J Antimicrob Chemother; 2009 Oct; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-resistant tuberculosis: issues in epidemiology and challenges for public health.
    Rieder HL
    Tuber Lung Dis; 1994 Oct; 75(5):321-3. PubMed ID: 7841423
    [No Abstract]   [Full Text] [Related]  

  • 33. The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam.
    Buu TN; Huyen MN; Lan NT; Quy HT; Hen NV; Zignol M; Borgdorff MW; Cobelens FG; van Soolingen D
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):900-6. PubMed ID: 19555542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis in migrants from 106 countries to Italy, 2008-2014.
    Fattorini L; Mustazzolu A; Borroni E; Piccaro G; Giannoni F; Cirillo DM;
    Eur Respir J; 2016 Apr; 47(4):1273-6. PubMed ID: 26846829
    [No Abstract]   [Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis outbreak in South Africa.
    Ismail NA; McCarthy K; Conradie F; Stevens W; Ndjeka N
    Lancet Infect Dis; 2019 Feb; 19(2):134-135. PubMed ID: 30528116
    [No Abstract]   [Full Text] [Related]  

  • 37. Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey.
    Lim DR; Dean AS; Taguinod-Santiago MR; Borbe-Reyes A; Cabibbe AM; Zignol M; Basilio RP; Garfin AMC; Ama MCG
    Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29496754
    [No Abstract]   [Full Text] [Related]  

  • 38. Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems.
    Villa S; Tagliani E; Borroni E; Castellotti PF; Ferrarese M; Ghodousi A; Lamberti A; Senatore S; Faccini M; Cirillo DM; Codecasa LR
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 34049944
    [No Abstract]   [Full Text] [Related]  

  • 39. Biomedical research. Hughes backs institute at epicenter of HIV and resistant TB.
    Koenig R
    Science; 2009 Mar; 323(5922):1659. PubMed ID: 19325090
    [No Abstract]   [Full Text] [Related]  

  • 40. The global burden of tuberculosis--combating drug resistance in difficult times.
    Donald PR; van Helden PD
    N Engl J Med; 2009 Jun; 360(23):2393-5. PubMed ID: 19494214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.